Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of four methods for platelet compatibility testing.

J G McFarland, R H Aster

    Blood
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2018
    Same author

    Human platelet antigens - 2013.

    Vox sanguinis·2013
    Same author

    Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.

    Journal of thrombosis and haemostasis : JTH·2012
    Same author

    Detection and identification of platelet antibodies and antigens in the clinical laboratory.

    Immunohematology·2010
    Same author

    Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.

    Journal of thrombosis and haemostasis : JTH·2009
    Same author

    HPA-1a/b(PlA1/A2,Zwa/b): the odyssey of an alloantigen system.

    Immunohematology·2007

    The monoclonal anti-IgG assay (MAIA) best predicts platelet transfusion success in patients refractory to random-donor platelets. MAIA offers valuable insights into antibody types causing transfusion failures.

    Area of Science:

    • Immunology
    • Transfusion Medicine

    Background:

    • Patients refractory to platelet transfusions often have alloantibodies complicating treatment.
    • Identifying the specific antibodies is crucial for successful transfusion strategies.

    Purpose of the Study:

    • To evaluate the predictive power of four platelet compatibility assays for transfusion outcomes.
    • To determine the most effective assay for guiding platelet transfusion decisions in refractory patients.

    Main Methods:

    • Four assays were performed: monoclonal anti-IgG assay (MAIA), platelet suspension immunofluorescence (PSIFT), 51Cr release, and microlymphocytotoxicity.
    • Samples from 38 HLA-matched donor/recipient pairs undergoing 55 single-donor platelet transfusions were analyzed.
    • Predictive accuracy for post-transfusion platelet recovery at 1 and 24 hours was assessed.

    Related Experiment Videos

    Main Results:

    • MAIA demonstrated the highest predictability for platelet recovery (74% at 1 hour, 76% at 24 hours).
    • PSIFT showed significant predictability (63% at 1 hour), while other assays were less effective.
    • HLA compatibility level did not influence MAIA's predictive ability.

    Conclusions:

    • MAIA is the most effective assay for predicting platelet transfusion outcomes in refractory patients.
    • MAIA may differentiate between HLA, ABO, and platelet-specific antibodies causing transfusion failure.
    • This assay can guide the selection of compatible platelets for challenging transfusion cases.